2d
Gear Patrol on MSNDid a Motorcycle Brand You’ve Never Heard of Secretly Make the Perfect Entry-Level Cruiser?Straight out of Jiangsu Province, China, Hanway’s YP500 packs plenty of retro bobber style and just enough power to scratch ...
Moto Anatomy X Royal Enfield has announced its Royal Enfield Slide School 2025 spring schedule. Students will train on the ...
Royal Enfield has launched the Shotgun 650 Icon Edition. The limited-run bike has been designed in collaboration with Icon Motorsport's custom and will only have 100 units available. All of these ...
A collaboration between Royal Enfield and Icon Motorsports sees the release of the Limited Edition Shotgun 650, priced at RM38,500. Produced in a limited run of only 100 units worldwide ...
Royal Enfield has created a new limited-edition version of its Shotgun 650 middleweight motorcycle. Built in collaboration with custom motorcycle and rider-wear firm Icon Motosports, the small-run ...
They are Jean-Pierre Chevènement, who held several ministerial portfolios in France, such as interior, defense and education, and Ségolène Royal, a former candidate in the 2007 French presidential ...
picture alliance / Contributor The widely followed Standard & Poor’s 500 Index is the standard by which stock market performance in the U.S. is often measured, as it tracks 500 of the largest ...
HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United ...
Let’s see how the two of them went about the customization process. It all started with a Royal Enfield Classic 500 from the model-year 2012, and the aim was to convert it into a stylish cafe ...
“Completing enrollment in our Phase 1b trial marks an important milestone for the HB-500 program and our strategic collaboration with Gilead and speaks to the focus on operational excellence at ...
HOOKIPA Pharma Inc. has announced the completion of participant enrollment in a Phase 1b clinical trial for HB-500, a next-generation therapeutic vaccine aimed at treating HIV. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results